Linezolid for the treatment of multidrug-resistant tuberculosis | Zendy

Jesús Fortün | Zendy; Pilar MartínDávila | Zendy; Enrique Navas | Zendy; María Jesús PérezElías | Zendy; Javier Cobo | Zendy; Marta Tato | Zendy; Elia Gómez-G. de la Pedrosa | Zendy; E Gómez-Mampaso | Zendy; Santiago Moreno | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Linezolid for the treatment of multidrug-resistant tuberculosis

Author(s) -

Jesús Fortün,

Pilar MartínDávila,

Enrique Navas,

María Jesús PérezElías,

Javier Cobo,

Marta Tato,

Elia Gómez-G. de la Pedrosa,

E Gómez-Mampaso,

Santiago Moreno

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki148

Subject(s) - linezolid , medicine , clofazimine , tuberculosis , adverse effect , ethambutol , regimen , surgery , multiple drug resistance , mycobacterium tuberculosis , drug resistance , microbiology and biotechnology , immunology , vancomycin , pathology , biology , staphylococcus aureus , leprosy , bacteria , genetics

In vitro studies have shown good activity of linezolid against Mycobacterium tuberculosis, including multidrug-resistant strains. However, clinical experience with linezolid in tuberculosis is scarce.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research